Johnson & Johnson (JNJ) PB Ratio: 7.24
Is Johnson & Johnson’s P/B ratio high or low?
Johnson & Johnson's P/B ratio of 7.24 is 23% above its 5-year average of 5.88, near the high end of its 5-year range (4.54–7.43).
16.57% above its 12-month average of 6.21.
JNJ PB Ratio Chart
JNJ Average PB Ratio Chart
JNJ Current vs Average PB Ratio Chart
JNJ PB Ratio Metrics
PB RATIO
7.24
PB RATIO AVG TTM
6.21
PB RATIO AVG 3Y
5.69
PB RATIO AVG 5Y
5.88
PB RATIO AVG 10Y
5.80
PB RATIO AVG 15Y
5.07
PB RATIO AVG 20Y
4.77
CURRENT VS TTM AVG
+16.57%
CURRENT VS 3Y AVG
+27.22%
CURRENT VS 5Y AVG
+23.07%
CURRENT VS 10Y AVG
+24.89%
CURRENT VS 15Y AVG
+42.89%
CURRENT VS 20Y AVG
+51.70%
JNJ Competitors' PB Ratio
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Johnson & Johnson (JNJ) | $577.73B | 7.24 | 6.21 | 5.69 | 5.88 |
| Pfizer Inc. (PFE) | $149.61B | 1.67 | 1.63 | 1.71 | 2.35 |
| Merck & Co., Inc. (MRK) | $298.23B | 6.51 | 4.98 | 6.03 | 5.97 |
| AbbVie Inc. (ABBV) | $399.86B | 14.59 | 147.05 | 61.32 | 40.26 |
| Eli Lilly and Company (LLY) | $1.10T | 33.39 | 37.03 | 47.81 | 41.64 |
| Bristol-Myers Squibb Company (BMY) | $116.13B | 5.79 | 5.81 | 5.35 | 4.99 |
P/B vs. its own history
At 7.24, P/B is richer than usual, sitting higher than 99% of its 20-year history.
20-year low
2.69
median
4.66
20-year high
7.43
Book Value Analysis
P/B Ratio
7.24
Market Price / Book Value per Share
Johnson & Johnson PB Ratio Formula & Definition
PB Ratio = Market Cap / Total Shareholders' Equity
The price-to-book ratio compares market capitalization to book value (shareholders' equity). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Johnson & Johnson PB Ratio FAQ
- What is the P/B ratio for Johnson & Johnson (JNJ)?
- The P/B ratio for JNJ stock is 7.24.
- Is Johnson & Johnson's P/B ratio high or low?
- Johnson & Johnson's P/B ratio of 7.24 is 23% above its 5-year average of 5.88, near the high end of its 5-year range (4.54–7.43).
- What is the TTM average P/B ratio for Johnson & Johnson (JNJ)?
- The TTM average P/B ratio for JNJ stock is 6.21.
- What is the 3Y average P/B ratio for Johnson & Johnson (JNJ)?
- The 3Y average P/B ratio for JNJ stock is 5.69.
- What is the 5Y average P/B ratio for Johnson & Johnson (JNJ)?
- The 5Y average P/B ratio for JNJ stock is 5.88.
- What is the 10Y average P/B ratio for Johnson & Johnson (JNJ)?
- The 10Y average P/B ratio for JNJ stock is 5.80.
- What is the 15Y average P/B ratio for Johnson & Johnson (JNJ)?
- The 15Y average P/B ratio for JNJ stock is 5.07.
- What is the 20Y average P/B ratio for Johnson & Johnson (JNJ)?
- The 20Y average P/B ratio for JNJ stock is 4.77.
Johnson & Johnson PB Ratio History
| DATE | PB RATIO |
|---|---|
| 2026-06-11 | 7.24 |
| 2026-06-10 | 7.18 |
| 2026-06-09 | 7.14 |
| 2026-06-08 | 6.99 |
| 2026-06-05 | 7.01 |
| 2026-06-04 | 6.87 |
| 2026-06-03 | 6.72 |
| 2026-06-02 | 6.71 |
| 2026-06-01 | 6.73 |
| 2026-05-29 | 6.79 |
| 2026-05-28 | 6.95 |
| 2026-05-27 | 6.97 |
| 2026-05-26 | 6.93 |
| 2026-05-22 | 7.06 |
| 2026-05-21 | 6.98 |
| 2026-05-20 | 6.91 |
| 2026-05-19 | 6.93 |
| 2026-05-18 | 6.89 |
| 2026-05-15 | 6.83 |
| 2026-05-14 | 6.95 |
| 2026-05-13 | 6.94 |
| 2026-05-12 | 6.75 |
| 2026-05-11 | 6.67 |
| 2026-05-08 | 6.67 |
| 2026-05-07 | 6.70 |
| 2026-05-06 | 6.77 |
| 2026-05-05 | 6.79 |
| 2026-05-04 | 6.75 |
| 2026-05-01 | 6.84 |
| 2026-04-30 | 6.92 |
| 2026-04-29 | 6.85 |
| 2026-04-28 | 6.86 |
| 2026-04-27 | 6.79 |
| 2026-04-24 | 6.85 |
| 2026-04-23 | 6.95 |
| 2026-04-22 | 6.81 |
| 2026-04-21 | 6.76 |
| 2026-04-20 | 6.90 |
| 2026-04-17 | 7.00 |
| 2026-04-16 | 7.02 |
| 2026-04-15 | 7.14 |
| 2026-04-14 | 7.18 |
| 2026-04-13 | 7.12 |
| 2026-04-10 | 7.13 |
| 2026-04-09 | 7.22 |
| 2026-04-08 | 7.22 |
| 2026-04-07 | 7.13 |
| 2026-04-06 | 7.21 |
| 2026-04-02 | 7.27 |
| 2026-04-01 | 7.30 |
| 2026-03-31 | 7.31 |
| 2026-03-30 | 7.25 |
| 2026-03-27 | 7.19 |
| 2026-03-26 | 7.16 |
| 2026-03-25 | 7.18 |
| 2026-03-24 | 7.04 |
| 2026-03-23 | 7.04 |
| 2026-03-20 | 7.04 |
| 2026-03-19 | 7.11 |
| 2026-03-18 | 7.10 |
| 2026-03-17 | 7.12 |
| 2026-03-16 | 7.27 |
| 2026-03-13 | 7.22 |
| 2026-03-12 | 7.24 |
| 2026-03-11 | 7.27 |
| 2026-03-10 | 7.29 |
| 2026-03-09 | 7.26 |
| 2026-03-06 | 7.19 |
| 2026-03-05 | 7.17 |
| 2026-03-04 | 7.34 |
| 2026-03-03 | 7.38 |
| 2026-03-02 | 7.43 |
| 2026-02-27 | 7.43 |
| 2026-02-26 | 7.28 |
| 2026-02-25 | 7.33 |
| 2026-02-24 | 7.37 |
| 2026-02-23 | 7.35 |
| 2026-02-20 | 7.25 |
| 2026-02-19 | 7.39 |
| 2026-02-18 | 7.33 |
| 2026-02-17 | 7.28 |
| 2026-02-13 | 7.28 |
| 2026-02-12 | 7.31 |
| 2026-02-11 | 7.20 |
| 2026-02-10 | 7.30 |
| 2026-02-09 | 7.31 |
| 2026-02-06 | 7.35 |
| 2026-02-05 | 7.28 |
| 2026-02-04 | 7.18 |
| 2026-02-03 | 7.14 |
| 2026-02-02 | 7.07 |
| 2026-01-30 | 6.96 |
| 2026-01-29 | 6.96 |
| 2026-01-28 | 6.98 |
| 2026-01-27 | 6.88 |
| 2026-01-26 | 6.79 |
| 2026-01-23 | 6.74 |
| 2026-01-22 | 6.69 |
| 2026-01-21 | 6.68 |
| 2026-01-20 | 6.68 |
| 2026-01-16 | 6.70 |
| 2026-01-15 | 6.73 |
| 2026-01-14 | 6.70 |
| 2026-01-13 | 6.55 |
| 2026-01-12 | 6.42 |
| 2026-01-09 | 6.26 |
| 2026-01-08 | 6.30 |
| 2026-01-07 | 6.36 |
| 2026-01-06 | 6.27 |
| 2026-01-05 | 6.26 |
| 2026-01-02 | 6.35 |
| 2025-12-31 | 6.34 |
| 2025-12-30 | 6.34 |
| 2025-12-29 | 6.36 |
| 2025-12-26 | 6.36 |
| 2025-12-24 | 6.37 |
| 2025-12-23 | 6.30 |
| 2025-12-22 | 6.35 |
| 2025-12-19 | 6.32 |
| 2025-12-18 | 6.38 |
| 2025-12-17 | 6.44 |
| 2025-12-16 | 6.41 |
| 2025-12-15 | 6.56 |
| 2025-12-12 | 6.48 |
| 2025-12-11 | 6.43 |
| 2025-12-10 | 6.33 |
| 2025-12-09 | 6.13 |
| 2025-12-08 | 6.18 |
| 2025-12-05 | 6.19 |
| 2025-12-04 | 6.20 |
| 2025-12-03 | 6.29 |
| 2025-12-02 | 6.29 |
| 2025-12-01 | 6.29 |
| 2025-11-28 | 6.34 |
| 2025-11-26 | 6.36 |
| 2025-11-25 | 6.33 |
| 2025-11-24 | 6.31 |
| 2025-11-21 | 6.25 |
| 2025-11-20 | 6.22 |
| 2025-11-19 | 6.20 |
| 2025-11-18 | 6.13 |
| 2025-11-17 | 6.11 |
| 2025-11-14 | 6.00 |
| 2025-11-13 | 5.98 |
| 2025-11-12 | 5.96 |
| 2025-11-11 | 5.94 |
| 2025-11-10 | 5.77 |
| 2025-11-07 | 5.72 |
| 2025-11-06 | 5.73 |
| 2025-11-05 | 5.70 |
| 2025-11-04 | 5.72 |
| 2025-11-03 | 5.71 |
| 2025-10-31 | 5.79 |
| 2025-10-30 | 5.79 |
| 2025-10-29 | 5.72 |
| 2025-10-28 | 5.73 |
| 2025-10-27 | 5.83 |
| 2025-10-24 | 5.83 |
| 2025-10-23 | 5.90 |
| 2025-10-22 | 5.91 |
| 2025-10-21 | 5.92 |
| 2025-10-20 | 5.97 |
| 2025-10-17 | 5.96 |
| 2025-10-16 | 5.92 |
| 2025-10-15 | 5.89 |
| 2025-10-14 | 5.88 |
| 2025-10-13 | 5.88 |
| 2025-10-10 | 5.88 |
| 2025-10-09 | 5.89 |
| 2025-10-08 | 5.85 |
| 2025-10-07 | 5.82 |
| 2025-10-06 | 5.80 |
| 2025-10-03 | 5.82 |
| 2025-10-02 | 5.73 |
| 2025-10-01 | 5.74 |
| 2025-09-30 | 5.72 |
| 2025-09-29 | 5.60 |
| 2025-09-26 | 5.54 |
| 2025-09-25 | 5.48 |
| 2025-09-24 | 5.45 |
| 2025-09-23 | 5.44 |
| 2025-09-22 | 5.37 |
| 2025-09-19 | 5.43 |
| 2025-09-18 | 5.37 |
| 2025-09-17 | 5.46 |
| 2025-09-16 | 5.44 |
| 2025-09-15 | 5.47 |
| 2025-09-12 | 5.49 |
| 2025-09-11 | 5.50 |
| 2025-09-10 | 5.42 |
| 2025-09-09 | 5.46 |
| 2025-09-08 | 5.49 |
| 2025-09-05 | 5.50 |
| 2025-09-04 | 5.51 |
| 2025-09-03 | 5.49 |
| 2025-09-02 | 5.49 |
| 2025-08-29 | 5.46 |
| 2025-08-28 | 5.41 |
| 2025-08-27 | 5.45 |
| 2025-08-26 | 5.44 |
| 2025-08-25 | 5.50 |
| 2025-08-22 | 5.53 |
| 2025-08-21 | 5.52 |
| 2025-08-20 | 5.51 |
| 2025-08-19 | 5.48 |
| 2025-08-18 | 5.43 |
| 2025-08-15 | 5.45 |
| 2025-08-14 | 5.39 |
| 2025-08-13 | 5.38 |
| 2025-08-12 | 5.33 |
| 2025-08-11 | 5.36 |
| 2025-08-08 | 5.34 |
| 2025-08-07 | 5.29 |
| 2025-08-06 | 5.26 |
| 2025-08-05 | 5.26 |
| 2025-08-04 | 5.27 |
| 2025-08-01 | 5.16 |
| 2025-07-31 | 5.08 |
| 2025-07-30 | 5.16 |
| 2025-07-29 | 5.18 |
| 2025-07-28 | 5.12 |
| 2025-07-25 | 5.19 |
| 2025-07-24 | 5.23 |
| 2025-07-23 | 5.25 |
| 2025-07-22 | 5.21 |
| 2025-07-21 | 5.10 |
| 2025-07-18 | 5.08 |
| 2025-07-17 | 5.06 |
| 2025-07-16 | 5.11 |
| 2025-07-15 | 4.82 |
| 2025-07-14 | 4.87 |
| 2025-07-11 | 4.87 |
| 2025-07-10 | 4.89 |
| 2025-07-09 | 4.85 |
| 2025-07-08 | 4.83 |
| 2025-07-07 | 4.82 |
| 2025-07-03 | 4.84 |
| 2025-07-02 | 4.83 |
| 2025-07-01 | 4.84 |
| 2025-06-30 | 4.74 |
| 2025-06-27 | 4.73 |
| 2025-06-26 | 4.72 |
| 2025-06-25 | 4.73 |
| 2025-06-24 | 4.72 |
| 2025-06-23 | 4.70 |
| 2025-06-20 | 4.65 |
| 2025-06-18 | 4.68 |
| 2025-06-17 | 4.73 |
| 2025-06-16 | 4.82 |
| 2025-06-13 | 4.87 |
| 2025-06-12 | 4.86 |
| 2025-06-11 | 4.82 |
| 2025-06-10 | 4.85 |
| 2025-06-09 | 4.82 |
| 2025-06-06 | 4.81 |
| 2025-06-05 | 4.77 |
| 2025-06-04 | 4.75 |
| 2025-06-03 | 4.79 |
| 2025-06-02 | 4.82 |
| 2025-05-30 | 4.82 |
Showing the most recent 260 of 5,032 data points. The chart above shows the full history.
Related Metrics
About Johnson & Johnson
Johnson & Johnson (JNJ) operates globally, engaging in the research, development, production, and distribution of a diverse range of healthcare products. In a pivotal strategic move in 2023, the company divested its Consumer Health division, establishing it as the independent entity Kenvue Inc. This separation was implemented to allow J&J to sharpen its focus on higher-growth, innovation-led areas. Consequently, well-known consumer brands like TYLENOL, LISTERINE, and BAND-AID are now part of Kenvue's portfolio. Johnson & Johnson's current operations are centered around two primary divisions: Innovative Medicine and MedTech. The Innovative Medicine segment, formerly known as Pharmaceuticals, specializes in prescription drugs designed to treat complex ailments such as rheumatoid arthritis, various forms of cancer, HIV/AIDS, and neurodegenerative disorders. Its MedTech division, encompassing Medical Devices, delivers cutting-edge technological solutions, including electrophysiology equipment, neurovascular care products, orthopaedic implants for hips, knees, and spine, advanced surgical technologies, and ACUVUE brand disposable contact lenses. These two streamlined segments primarily cater to a client base comprising hospitals, medical professionals, wholesale distributors, and retail outlets. From its headquarters in New Brunswick, New Jersey, Johnson & Johnson continues to uphold its enduring mission of advancing human health, a commitment it has maintained since its founding in 1886.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Joaquin Duato